Cost-effectiveness of hypertension therapy according to 2014 guidelines. - sprookjes - yvandenbroek - TriplyDB

Cost-effectiveness of hypertension therapy according to 2014 guidelines.

Cost-effectiveness of hypertension therapy according to 2014 guidelines.

http://www.wikidata.org/entity/Q35493852

about

US Hypertension Management Guidelines: A Review of the Recent Past and Recommendations for the Future The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin.Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment."They're younger… it's harder." Primary providers' perspectives on hypertension management in young adults: a multicenter qualitative study.Telemonitoring and Protocolized Case Management for Hypertensive Community-Dwelling Seniors With Diabetes: Protocol of the TECHNOMED Randomized Controlled Trial.Cost-effectiveness of pharmacist care for managing hypertension in Canada Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study.Cost-effectiveness of Antihypertensive Medication: Exploring Race and Sex Differences Using Data From the REasons for Geographic and Racial Differences in Stroke Study.Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage Nox and Inflammation in the Vascular Adventitia.Evidence to Maintain the Systolic Blood Pressure Treatment Threshold at 140 mm Hg for Stroke Prevention: The Northern Manhattan Study Reducing the Blood Pressure-Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control.Cardiovascular diseases in mega-countries: the challenges of the nutrition, physical activity and epidemiologic transitions, and the double burden of disease.Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model Gait Speed as a Guide for Blood Pressure Targets in Older Adults: A Modeling Study Health expenditures spent for prevention, economic performance, and social welfare Update on blood pressure control and renal outcomes in diabetes mellitus.New Hypertension Guidelines: Progression or a Step Backwards in Hypertension?Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control.A Round-Up on Cost-Effectiveness of Hypertension Therapy Based on the 2014 Guidelines.Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves.High Blood Pressure in Sub-Saharan Africa: Why Prevention, Detection, and Control are Urgent and Important.Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine.Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.Cost-effectiveness of Intensive Blood Pressure Management.Comparative effectiveness of antihypertensive drugs in nondiabetic patients with hypertension: A population-based study.Why Do Health Economists Promote Technology Adoption Rather Than the Search for Efficiency? A Proposal for a Change in Our Approach to Economic Evaluation in Health Care.Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study.Comparing Strategies for Lipid Lowering in Argentina: An Analysis from the CVD Policy Model-Argentina.Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when.Why should we screen for arterial hypertension in children and adolescents?Barnidipine Real-Life Efficacy and Tolerability in Arterial Hypertension: Results from Younger and Older Patients in the BASIC-HT Study.Incremental effects of antihypertensive drugs: instrumental variable analysis.Influence of high risk of obstructive sleep apnea on adherence to antihypertensive treatment in outpatients.The Relationship Between Cognitive Functioning and the JNC-8 Guidelines for Hypertension in Older Adults.Patient Experience with Care and its Association with Adherence to Hypertension Medications.Capsule Commentary on Murray et al. Antihypertensive Medication and Dementia Risk in Older Adult African-Americans with Hypertension: a Prospective Cohort Study.The effects of increasing calcium channel blocker dose vs. adding a diuretic to treatment regimens for patients with uncontrolled hypertension.

P2860

Q28081091-319DECF3-F903-424B-97B4-5A016F834EEA Q28546995-C800BC89-3C82-476A-8EE9-2DCCC9575320 Q30238784-82366DD4-2AEC-4F43-B784-FE7DA6FF19D1 Q30248710-85E4DAA6-3B4E-4B1E-B95E-96B0331BC51E Q30489448-9324F74F-0A57-4D51-A0D6-F07ACF05142C Q30834096-57682AA0-F828-4EA8-8C5D-BE5B6CCE192D Q33167337-60CBD291-5F9B-4281-A677-88CDF3D0A994 Q33632515-66382A6A-8C30-4EFF-A491-02C91CD99D52 Q36179249-A834EFFE-FA01-4173-A354-9DAA45B50CE1 Q36319556-3F9E4BBD-D997-4527-8C6E-FB201E056B18 Q36533789-99CA9B2C-3745-433E-A028-B3399C07C693 Q36569976-E9E5A2B1-B9E5-43DF-82E1-9DDB163B115A Q36576594-C8AFE20F-8025-4896-86D4-7A10D88663A0 Q36835986-B2E9E348-985E-45D5-95D3-A0A3114A62F6 Q37100330-4219C5A0-AFF4-44ED-A314-0788CED2F635 Q37265528-E6F745F0-6E57-4B0B-96F0-0BE6B31DF610 Q37270274-D8A452AA-1B92-4BAC-8ECF-E5E61CFCAEC5 Q37273243-1C45DFD1-9A47-442D-886D-62B7A1F66F62 Q38492248-9A69E6AC-1611-4016-8C22-422DF02D6CD7 Q38525971-F7CEB5AF-8A21-4E56-A823-63E59B5988F9 Q38611655-FB912F24-B863-411B-8EE2-B5A56F7798D5 Q38721844-F184CAE0-8F7B-45CF-AAF8-2CB6B85798C7 Q38793913-18A4A306-9201-4BFA-9235-ADC7BE4CBFEE Q38930353-2E98443A-84C4-4BFE-A42D-E31E5982C8B8 Q39093960-9BD97742-ACB3-474A-A613-C577F526F80F Q39252137-ABA57B84-9DA4-49FB-9314-97BC3C0BEEE3 Q39390928-3A4909E2-9618-425F-8983-65F3087BB096 Q40103191-11CAA575-97A0-4675-BA3D-27FC427723C2 Q40694127-E257940D-EDBC-40FE-822C-9C227027CEE0 Q41629841-590B8613-CB86-4C00-819D-F715ABB928EB Q46227378-233D9781-B9E6-469D-B9AA-FC8D543A876F Q47097096-B3943004-8D2F-484E-B028-7FFC5C5D8BBE Q47138175-90BD7E63-269B-4E90-BADE-D62B88899051 Q47156402-F2F54FE1-09E1-4D95-8FC3-92D28F832123 Q47256502-D18DBD58-448B-4E4C-8784-FE1961702821 Q47757452-38A9D25E-7673-488B-ABCF-0C064FBC871F Q47927404-70FEF9D8-7E64-47E8-8EF3-997CF6C89C66 Q49668804-89CD6AFE-D4D5-4331-9DAC-5D51BD3A24E4 Q50193357-798340CC-BFF3-4C95-801E-F1FA2A2397AA Q50697785-8174C2C8-DBC5-48CD-8ECF-82E57C9BF4A3

P2860

Cost-effectiveness of hypertension therapy according to 2014 guidelines.

http://www.wikidata.org/entity/Q35493852

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Cost-effectiveness of hypertension therapy according to 2014 guidelines.

@ast

Cost-effectiveness of hypertension therapy according to 2014 guidelines.

@en

type

label

Cost-effectiveness of hypertension therapy according to 2014 guidelines.

@ast

Cost-effectiveness of hypertension therapy according to 2014 guidelines.

@en

prefLabel

Cost-effectiveness of hypertension therapy according to 2014 guidelines.

@ast

Cost-effectiveness of hypertension therapy according to 2014 guidelines.

@en

P1433

Q35493852-DB78C661-80B8-4BAE-988B-A5BF2DC0AA25

P1476

Q35493852-CC15D43C-25A3-4EDA-894B-048DE8C3EC21

P2093

Q35493852-0C4BB9D2-4F60-48B4-8607-C9EC68F660A8

Q35493852-35A6F3BD-ECCF-4AF2-8A70-D3929F549BD9

Q35493852-40308A54-9803-4D9C-91CF-B0524AA6202A

Q35493852-557F8EA2-68D5-478D-B6C7-AFBAE9FFC97D

Q35493852-6CA7A1C9-46A7-4FB6-B88B-48B601EC50EB

Q35493852-ABB2F15B-2767-4512-9B86-F9657192D623

Q35493852-B0B91FAD-32BB-4270-9C60-B21900EBE63F

Q35493852-E42B58A9-5041-4B4D-B7AE-6E002DBDFB93

Q35493852-E6D255D0-5C06-4A98-9244-53FAA9A59122

P2860

Q35493852-10286BF9-E250-4E8B-9AE0-79849C998A91

Q35493852-127E55CD-D452-4D28-97A1-75764C67A1A3

Q35493852-17082CB6-2D38-4E50-9301-AD1E1A67DC2D

Q35493852-272E78E7-55B5-4775-AA4B-A305513E9C48

Q35493852-2B92CBB2-6D2F-4885-8DA5-84D2A6138149

Q35493852-388C9F0C-A6BC-4751-B79C-5BFF21D3AB7C

Q35493852-3AEF15E0-E016-442F-AB87-F3FA2CD4E935

Q35493852-3D505384-3EB0-4D06-B17E-794E1E9B0645

Q35493852-51E3B706-C2EA-4F7A-9920-308DCDB39F90

Q35493852-6011F3C4-4103-4DFE-A011-67C40D205397

P304

Q35493852-AD221C3D-B37B-4EBD-914D-2975DBFD6E16

P31

Q35493852-BB58C326-3183-4D3D-B02F-953F27C51991

P356

Q35493852-A42AF659-2F67-4B86-9CB9-303A0ECF3AE1

P407

Q35493852-3835EC45-1FD3-4AD0-BD1B-552BFFC98E0C

P433

Q35493852-5FC67C5C-3A46-4D21-9C38-5A1E3357A6B7

P478

Q35493852-FC36D43A-53D4-4231-B75E-348AB075479E

P50

Q35493852-90771EB1-33D8-4892-8FE0-0AED40675DCB

P577

Q35493852-DBE188AA-C897-40D4-8670-85F572286CA0

P5875

Q35493852-66C82330-C4A3-4BC2-B858-4854C09A47B2

P698

Q35493852-8323914C-E385-42A9-A937-BC2427F508CD

P932

Q35493852-2C7BD1B3-C7B3-4172-83C7-3C76C8737726

P356

P1433

The New England Journal of Medicine

P1476

Cost-effectiveness of hypertension therapy according to 2014 guidelines.

@en

P2093

Andrew E Moran

http://www.w3.org/2001/XMLSchema#string

Anusorn Thanataveerat

http://www.w3.org/2001/XMLSchema#string

David Guzman

http://www.w3.org/2001/XMLSchema#string

Keane Y Tzong

http://www.w3.org/2001/XMLSchema#string

Lawrence Williams

http://www.w3.org/2001/XMLSchema#string

Lee Goldman

http://www.w3.org/2001/XMLSchema#string

Michelle C Odden

http://www.w3.org/2001/XMLSchema#string

Pamela G Coxson

http://www.w3.org/2001/XMLSchema#string

Petra W Rasmussen

http://www.w3.org/2001/XMLSchema#string

P2860

The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors

Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View

An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors

Interventions used to improve control of blood pressure in patients with hypertension

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

P304

447-455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMSA1406751

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

372

http://www.w3.org/2001/XMLSchema#string

P50

Kirsten Bibbins-Domingo

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271597980

http://www.w3.org/2001/XMLSchema#string

P698

25629742

http://www.w3.org/2001/XMLSchema#string

P932

4403858

http://www.w3.org/2001/XMLSchema#string